2030 年までの北米迅速検査キット市場予測 - 地域別分析 - タイプ別 (迅速抗原検査、迅速抗体検査など)、製品別 (市販迅速検査キットおよびプロ用迅速検査キット)、技術別 (ラテラルフローアッセイ、固相、凝集、免疫スポットアッセイ、細胞成分ベース)、用途別 (血糖検査、感染症検査、妊娠および生殖能力、心臓代謝検査など)、エンドユーザー別 (病院および診療所、在宅ケア、診断センターなど)
遺伝性疾患と感染症の罹患率の上昇が北米の迅速検査キット市場を活性化
MJH Life Sciences（米国）による2022年のレポートでは、毎年世界中で30万人の新生児が鎌状赤血球症を持って生まれていると推定されています。CDCによると、アフリカ系アメリカ人の500人に1人が鎌状赤血球症に罹患しています。世界保健機関（WHO）の最新の世界マラリア報告書（WMR）2022によると、2020年に記録された2億4,500万件と比較して、2021年には世界で約2億4,700万件の新たなマラリア症例が報告されています。同じ情報源によると、2021年のマラリアによる死亡者数は619,000人でした。
鎌状赤血球スキャンは、鎌状赤血球貧血を高い感度と特異性で特定するための迅速検査です。迅速診断検査（RDT）は、人間の血液中のマラリア原虫の存在を検出することにより、マラリアの診断に役立ちます。高品質の顕微鏡検査サービスへのアクセスが限られている場合、臨床診断または顕微鏡ベースの診断の代替として放射線診断技術が使用されます。COVID-19パンデミックは、迅速検査キット市場に大きな影響を与えました。ほぼすべての診断検査では、SARS-CoV-2感染の症状を示した人を検査するためにリアルタイムPCRを使用しました。迅速検査キットは、ほぼどこにでも存在し、堅牢で信頼性があります。遺伝子型判定、クローニング、および一塩基変異解析のために特定の DNA 領域を増幅する迅速検査技術は、ほとんどの分子生物学研究室で使用されています。したがって、遺伝性疾患および感染症の発生率の増加が、迅速検査キット市場の成長を促進しています。
北米迅速検査キット市場の概要
研究および治療における CRISPR や PCR などの遺伝子合成および編集ツールの急速な導入により、迅速な定量化、変更、および観察に役立つアッセイが必要になります。米国は、公的機関および民間組織から多額の資金提供を求めており、高度な研究方法論に多額の投資を行うことが期待されており、迅速検査キット市場で主導的な地位を占めると予想されています。パンデミックの SARS-CoV-2 デルタとオミクロンが優勢な期間の間に、在宅検査の使用が急増しました。 CDCによると、2023年4月には、米国全土で7,000万以上の検査キットが出荷されました。
北米の迅速検査キット市場の収益と2030年までの予測（百万米ドル）
北米の迅速検査キット市場のセグメンテーション
北米の迅速検査キット市場は、タイプ、製品、技術、アプリケーション、エンドユーザー、および国に基づいてセグメント化されています。タイプに基づいて、北米の迅速検査キット市場は、迅速抗原検査、迅速抗体検査、およびその他のカテゴリに分類されています。迅速抗原検査セグメントは、2022年に最大の市場シェアを占めました。
製品別に見ると、北米の迅速検査キット市場は、店頭販売の迅速検査キットとプロフェッショナル向け迅速検査キットに分かれています。 2022年には、店頭販売の迅速検査キットセグメントがより大きな市場シェアを占めました。
技術別に見ると、北米の迅速検査キット市場は、ラテラルフローアッセイ、固相、凝集、免疫スポットアッセイ、細胞成分ベースに分類されています。ラテラルフローアッセイセグメントは、2022年に最大の市場シェアを占めました。
用途別に見ると、北米の迅速検査キット市場は、血糖検査、感染症検査、妊娠・不妊、心血管代謝検査などに分類されています。血糖検査セグメントは、2022年に最大の市場シェアを占めました。
エンドユーザー別に見ると、北米の迅速検査キット市場は、病院・診療所、在宅ケア、診断センターなどに分類されています。病院・診療所セグメントは、2022年に最大の市場シェアを占めました。
国別に見ると、北米の迅速検査キット市場は、米国、カナダ、メキシコに分類されています。 2022年、北米の迅速検査キット市場シェアは米国が独占しました。
北米の迅速検査キット市場で活動している大手企業には、F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、Guangzhou Wondfo Biotech Co Ltd、Denka Co Ltd、Abbott Laboratories、Trinity Biotech Plc、SD Biosensor Inc、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA、Beckman Coulter Incなどがあります。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - North America Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. North America Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Rapid Test Kits Market - Country Analysis
11.1 North America: Rapid Test Kits Market
11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 United States
11.1.1.1.1 Overview
11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 Canada
11.1.1.3.1 Overview
11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Mexico
11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 OraSure Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Guangzhou Wondfo Biotech Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Denka Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Abbott Laboratories
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Trinity Biotech Plc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 SD Biosensor Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Beckman Coulter Inc
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. OraSure Technologies Inc
10. Guangzhou Wondfo Biotech Co Ltd
11. Denka Co Ltd
12. Abbott Laboratories
13. Trinity Biotech Plc
14. SD Biosensor Inc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. DiaSorin SpA
18. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.